Delivery Order SPE2DB24D2101-SPE2DB24FKGQP

Award Date 9/18/24
Potential Completion Date 9/19/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,411.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, designated as SPE2DX, which has a total potential value of $999,999,999.00 and runs through December 2026. The contract is for the delivery of 4,568,090,381 units of "MUCUS RELIEF ER 600 MG TABLET 500S", a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,231.38 firm fixed-price delivery order is for the supply of MUCUS RELIEF ER 600 MG TABLET 500S, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $1,053.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566429897 MUCUS RELIEF ER 600 MG TABLET 500S, with a completion date of November 15, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside requirements, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of MUCUS RELIEF ER 600 MG TABLET 500S, a pharmaceutical product, with a ceiling value of $1,676.34 and a completion date of June 23, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,845.56 firm fixed-price delivery order is for the provision of "MUCUS RELIEF ER 600 MG TABLET 500S" and has an ultimate completion date of December 5, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical division,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,746.61, is for the delivery of "MUCUS RELIEF ER 600 MG TABLET 500S" and has a completion date of March 6, 2025. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,200.12, is a delivery order for the supply of "MUCUS RELIEF ER 600 MG TABLET 500S". The contract has an ultimate completion date of March 4, 2025 and is a firm fixed-price arrangement. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,728.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of MUCUS RELIEF ER 600 MG TABLET 500S. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of December 11, 2024. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has an extensive track record of federal...
This federal contract award, valued at $1,962.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for MUCUS RELIEF ER 600 MG TABLET 500S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 27, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,373.95 delivery order contract is for the supply of 500 tablets of Mucus Relief ER 600 mg. The contract has a firm fixed price and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB24FKGQP
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,860,724 units of Mucus Relief ER 600 mg tablets, with a total ceiling value of $1,383.96. The contract was awarded on September 18, 2024, with a completion date of September 19, 2024, and uses a Firm Fixed Price pricing type. This delivery order contract is not associated with a set-aside program. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award, which is likely part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This contract supports the DLA's mission of providing essential medical commodities, including pharmaceuticals, to military treatment facilities and other federal healthcare providers.

Generated 12/18/24, 9:26 AM